One obstacle in developing safer and more potent adjuvants is the lack of understanding about adjuvant mechanisms. Significant progress has been made in the last two decades in elucidation of mechanisms of commonly used adjuvants. Despite these advances, a complete understanding about their action mechanisms is still elusive. This project takes advantage of omics techniques with a current focus on proteomics to elucidate mechanisms of vaccine adjuvants and their synergistic effects.